Neuropathic pain, defined as pain caused by a lesion or disease of the somatosensory nervous system, does not act as a signal to warn the body of damage as acute pain does, and thus it does not have a ...

Lumbar stenosis is a common spinal condition that affects millions of people, particularly older adults. It occurs when the spinal canal located in the lower back experiences narrowing, putting ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for Bizengri (zenocutuzumab) as a promising treatment option. New research, ...

TRUSTED SINCE 2009 BY OVER ONE MILLION SATISFIED CUSTOMERS – Made in the USA in a certified facility and formulated by expert compound pharmacists and nutritionists, Nuturna is crafted for ...

It’s always a good idea to talk with your doctor about hair loss since they can help identify any medical conditions contributing to hair loss and recommend the right treatment. Want to explore ...

She began undergoing a rigorous treatment — seven surgeries, and up to 11 hours of chemotherapy, three times a week, which she estimated totaled about 180 chemotherapy treatments over nearly a ...

TOKYO, Japan - A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first clinical study of its kind, Japanese scientists said. There is ...

With this approval, the Catamaran is now indicated to treat the SI joint as either a stand-alone treatment or to augment a spinal fusion. "The FDA has cleared the Catamaran SI Joint Fusion System ...

TOKYO, March 24 — A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first clinical study of its kind, Japanese scientists said. There ...

Most non-surgical treatments for low back pain offer little benefit over placebo, with only a few showing modest effects. Better-quality research is urgently needed. Pooled data analysis shows that ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through ...